Promoter Tejash Maheshchandra Hathi discloses acquisition of 10,000 equity shares in Aptus Pharma Limited via off-market transaction on May 11, 2026.
The acquisition increases his total holding to 785,000 shares, representing 11.44% of the company's total voting capital.
Disclosure is made pursuant to Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to BSE Limited.
Company's total equity share capital remains unchanged at 6,860,000 shares of ₹10 each following this transaction.